THE DEAL, AT A GLANCE
From the announcementT-Therapeutics
01Who is involvedBacked by British Business Bank, Advent Life SciencesFrom the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗02What happenedT-Therapeutics raised $133M Series B, announced 2026-11-05From the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗03Why it mattersT-Therapeutics' $133M Series B is a large round within the tracked Unclassified sector, sitting at the 81th percentile by size.From the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗Click a part to explore its evidence. Unsupported imagery is withheld rather than guessed.Original record source ↗
T-Therapeutics · Financing Record
Explore source-linked visual explanations for T-Therapeutics. Unsupported claims are withheld while source review continues.
Record 15352 · Recorded date: 2026-11-05
What it does
Unsupported business claims are withheld pending source review. Explore the linked records for available evidence.
Explore company records →